Lisata Therapeutics, Inc.
No trades
No trades
Compare with Lisata Therapeutics, Inc.
Key facts today
Lisata Therapeutics (LSTA) won a U.S. method-of-use patent for certepetide in pancreatic and other solid tumors, expiring May 2041, with extra market exclusivity into November 2043. 1
−1.64 USD
−16.59 M USD
170.00 K USD
6.85 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
David J. Mazzo
Website
Headquarters
Basking Ridge
Founded
1980
IPO date
Nov 3, 1995
ISIN
US1280583022
CUSIP
128058302
FIGI
BBG000BNVDR4
Identifiers
ISIN US1280583022
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of LSTA is 1.20 USD — it has decreased by −3.31% in the past 24 hours. Watch Lisata Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lisata Therapeutics, Inc. stocks are traded under the ticker LSTA.
LSTA stock has fallen by −20.41% compared to the previous week, the month change is a −25.95% fall, over the last year Lisata Therapeutics, Inc. has showed a −49.37% decrease.
LSTA reached its all-time high on Jan 24, 2000 with the price of 637,500.00 USD, and its all-time low was 0.99 USD and was reached on Jul 31, 2026. View more price dynamics on LSTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LSTA stock is 15.93% volatile and has beta coefficient of −1.38. Track Lisata Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lisata Therapeutics, Inc. there?
Today Lisata Therapeutics, Inc. has the market capitalization of 10.54 M, it has decreased by −15.97% over the last week.
Yes, you can track Lisata Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Lisata Therapeutics, Inc. is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
LSTA net income for the last quarter is −2.93 M USD, while the quarter before that showed −4.49 M USD of net income which accounts for 0.00% change. Track more Lisata Therapeutics, Inc. financial stats to get the full picture.
No, LSTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 9, 2026, the company has 21 employees. See our rating of the largest employees — is Lisata Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lisata Therapeutics, Inc. EBITDA is −16.36 M USD, and current EBITDA margin is −10.63 K%. See more stats in Lisata Therapeutics, Inc. financial statements.
Like other stocks, LSTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lisata Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lisata Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lisata Therapeutics, Inc. stock shows the strong sell signal. See more of Lisata Therapeutics, Inc. technicals for a more comprehensive analysis.